Live tape
Top 8, mentions 7d10,067TSLA2,067 mentions▲ +0.05GOOGL1,609 mentions▲ +0.04NVDA1,231 mentions▲ +0.07CRWV1,216 mentions▲ +0.03SPCX1,103 mentions▲ +0.07QQQ1,076 mentions▲ +0.04META891 mentions▲ +0.05NBIS874 mentions▲ +0.06

Equity · Healthcare

ORKA

NASDAQ

Oruka Therapeutics, Inc.

$94 +2.17% vs prior close Finazon · prior-day close, indicative (IEX-derived, not the official close) · Sep 16, 2026
Price · Chart
25 sessions
$120 $90 12 Aug 16 Sep

The line runs $107.20 on 12 August through $94 on 16 September, on a scale from $90 to $120. Days the market did not trade hold the previous close, flat.

Track this symbol on TradingView TradingView chart · our licensed closes: 25 sessions, 12 Aug – 16 Sep 2026
Market cap $6.2B
52-week range $14.86 – $113
Avg volume 96.4K

as of Sep 16, 2026

ORKA insider trades

SEC Form 4 · last 90 days · newest reported trade 15 Oct 2026
Open-market buys 0
Open-market sells 16
Net sold $21.33M
Non-trade filings 12
Date Insider Type Shares Value
15 Oct 2026 Goncalves Joana Chief Medical Officer Sell 7,000 $524K
12 Oct 2026 Agarwal Arjun Senior Vice President, Finance Sell 9,999 $806K
01 Oct 2026 Klein Lawrence Otto Chief Executive Officer Sell 25,000 $2.09M
21 Sep 2026 Agarwal Arjun Senior Vice President, Finance Sell 533 $51K
21 Sep 2026 Quinlan Paul T General Counsel Sell 10,000 $936K
15 Sep 2026 Agarwal Arjun Senior Vice President, Finance Sell 560 $54K
15 Sep 2026 Goncalves Joana Chief Medical Officer Sell 7,947 $734K
15 Sep 2026 Klein Lawrence Otto Chief Executive Officer Sell 2,452 $235K
15 Sep 2026 Sandler Laura Lee Chief Operating Officer Sell 906 $87K
15 Sep 2026 Quinlan Paul T General Counsel Sell 1,039 $99K
11 Sep 2026 Agarwal Arjun Senior Vice President, Finance Sell 9,459 $872K
01 Sep 2026 Klein Lawrence Otto Chief Executive Officer Sell 75,000 $6.89M

Showing the 12 most recent of 16 open-market trades in this window. The figures above count all of them.

Compensation mechanics Share grants, option exercises, tax withholding and transfers. They reach the same Form 4 as a trade, but they are not the insider buying or selling on the open market, so no purchase or sale value applies to them.

Date Insider Type Shares Value
15 Oct 2026 Goncalves Joana Chief Medical Officer Option exercise 3,500 $24K
12 Oct 2026 Agarwal Arjun Senior Vice President, Finance Option exercise 9,999 $157K
01 Oct 2026 Klein Lawrence Otto Chief Executive Officer Option exercise 25,000 $195K
21 Sep 2026 Quinlan Paul T General Counsel Option exercise 10,000 $78K
15 Sep 2026 Goncalves Joana Chief Medical Officer Option exercise 3,500 $24K
11 Sep 2026 Agarwal Arjun Senior Vice President, Finance Option exercise 9,459 $150K
01 Sep 2026 Klein Lawrence Otto Chief Executive Officer Option exercise 75,000 $585K
01 Sep 2026 Sandler Laura Lee Chief Operating Officer Option exercise 5,000 $39K
24 Aug 2026 Edwards Larry Todd Chief Commercial Officer Award 100,000
17 Aug 2026 Goncalves Joana Chief Medical Officer Option exercise 3,500 $24K
14 Aug 2026 Quinlan Paul T General Counsel Option exercise 52,000 $603K
13 Aug 2026 Agarwal Arjun Senior Vice President, Finance Option exercise 10,000 $157K

ORKA reported financials

SEC EDGAR XBRL SEC EDGAR

ORKA reported net income of −$105.4M for the fiscal year ended 31 Dec 2025.

Figure Reported Period
Net income −$105.4M 31 Dec 2025 fiscal year
Total assets $1.1B 30 Jun 2026 at period end
Total equity $1.1B 30 Jun 2026 at period end

ORKA earnings

SEC EDGAR
Date Period EPS Revenue
30 Jun 2025 Q2 2025 −$0.46 —
31 Mar 2025 Q1 2025 −$0.40 —
31 Dec 2024 FY 2024 −$3.87 —
30 Sep 2024 Q3 2024 −$1.46 —
30 Jun 2024 Q2 2024 −$6.96 —
31 Mar 2024 Q1 2024 −$2.21 —
31 Dec 2023 FY 2023 −$0.37 —
30 Sep 2023 Q3 2023 −$0.10 —

Next report no date announced in SEC filings yet

Reported figures & scheduled dates · SEC EDGAR filings

ORKA institutional holders

SEC Form 13F SEC EDGAR

6 of the 45 institutional funds we track reported a ORKA position for the quarter ended 30 Jun 2026 — a combined $262.1M; the latest of those filings landed 02 Sep 2026.

Fund Action Shares Value
Viking Global Investors Trimmed −43.6% shares 1,503,478 $143.1M
Citadel Advisors Held (±25%) +11.1% shares 1,119,011 $106.5M
Fisher Asset Management New position 67,874 $6.5M
Millennium Management New position 32,866 $3.1M
AQR Capital Management Added +344.4% shares 18,697 $1.8M
Balyasny Asset Management New position 11,586 $1.1M
Two Sigma Investments Exited

ORKA fails-to-deliver

SEC CNS data SEC

On 25 Sep 2026, 138,421 shares of ORKA failed to deliver (about $11.8M).

Settlement date Shares failed Notional % of shares out
25 Sep 2026 138,421 $11.8M 0.209%
21 Sep 2026 54 $5K <0.001%
16 Sep 2026 349 $32K 0.001%
14 Sep 2026 47 $4K <0.001%

Sources

  1. Finazonprior-day close, indicative (IEX-derived, not the official close), some closes dollar-rounded at the source
  2. TradingViewthe price chart widget, drawn by TradingView from their own data
  3. SEC EDGARSEC EDGAR XBRL company facts · latest period ended 30 Jun 2026
  4. SEC EDGARSEC EDGAR 13F filings
  5. SECSEC fails-to-deliver (CNS) data
  6. SEC EDGARValuation computed from SEC EDGAR filings